VRIO Analysis of Aerpio Pharmaceuticals Inc

The Aerpio Pharmaceuticals Inc is exposed to, as well as has ownership of different resources. The Aerpio Pharmaceuticals Inc uses these resources for meeting its goals, as well as for developing and expanding different growth opportunities. The VRIO analysis is used by the Aerpio Pharmaceuticals Inc for assessing and evaluating these resources to help leadership and management to identify different strengths and weaknesses, and work towards using the same to enhance the business standing and proposition (Knott, 2015).

VRIO importance

More importantly, the VRIO analysis is used by the Aerpio Pharmaceuticals Inc to evaluate and identify the different competitive advantages that different resources can offer. In doing so, the Aerpio Pharmaceuticals Inc is able to identify resources that offer a long-term sustainable competitive advantage, and work towards building the same for increased opportunities (Chatzoglou, Chatzoudes, Sarigiannidis, & Theriou, 2018). Aerpio Pharmaceuticals Inc VRIO analysis is a strategic tool that allows the Aerpio Pharmaceuticals Inc to identify resources that offer a temporary competitive advantage – allowing the company to strategize tactics to then turn these into factors of long-term competitiveness.

The VRIO analysis largely assesses resources as being Valuable, rare, inimitable, and organized.

Valuable

Resources are valuable if they allow the Aerpio Pharmaceuticals Inc to enhance its efficiency and effectiveness through facilitating strategy implementation and realization. Moreover, resources are also valuable if they allow the Aerpio Pharmaceuticals Inc to successfully manage the threats it is exposed to, and capitalize on different opportunities through helping build internal strengths, and manage weaknesses appropriately (Lasserre, 2017). Some examples of valuable resources for Aerpio Pharmaceuticals Inc include the following:

Strong global presence

The Aerpio Pharmaceuticals Inc has a presence across various international locations and countries. The Aerpio Pharmaceuticals Inc has expanded its manufacturing operations across different countries in Asia and Europe. The Aerpio Pharmaceuticals Inc uses these manufacturing sites as central supply locations and hubs for different regions as well (Abratt & Bendixen, 2018).

Branch network

The Aerpio Pharmaceuticals Inc has a strong branch and store network across different regions in various international locations – including the UK, USA, China, and Australia, and across Europe. The Aerpio Pharmaceuticals Inc has developed its store network in locations that offer the company high visibility, and promise a high customer footfall (Baines, Fill, & Rosengren, 2017).

Supply chain management

Owing to the global presence, and international operations, the Aerpio Pharmaceuticals Inc also has an internally managed supply chain network. The supply chain network ensures consistently high quality, and timely manufacture and delivery of the products offered by the Aerpio Pharmaceuticals Inc to retailers, distributors, as well as end consumers (Chernev, 2018).

Risk management

The Aerpio Pharmaceuticals Inc has developed an internal means and system for identifying, managing, and mitigating environmental risks and threats. These risks include fluctuation in prices of raw materials, as well as political instability in regions where it operates. The internal risk management system for Aerpio Pharmaceuticals Inc comprises of continuous observation of the environment, and development of proactive strategies, as well as training of its personnel for responding to the same (Deepak & Jeyakumar, 2019).

Technological advancement

The Aerpio Pharmaceuticals Inc makes use of technological advancement for achieving economies of scale. The presence across various global locations has allowed the Aerpio Pharmaceuticals Inc to develop a seamless technological infrastructure for knowledge sharing. Aerpio Pharmaceuticals Inc is also able to implement processes of improvement internally (Iacobucci, 2021).

Use of AI

The Aerpio Pharmaceuticals Inc also makes use of AI for improving internal efficiencies and processes as well as for improving the consumer experience. The use of AI internally has allowed the Aerpio Pharmaceuticals Inc to reduce the error rates, and improve logistic management, for example.

User experience

The Aerpio Pharmaceuticals Inc focuses on enhancing the user experience for maintaining loyalty. The use of AI especially has allowed the company to improve the user experience through providing 24/7 customer support, as well as developing relevant purchase prompts for consumers based on their browsing histories (Sahaf, 2019).

Customer service

The customer service offered by Aerpio Pharmaceuticals Inc is an important and valuable resource that helps the company differentiate its offerings from that of the competition. The Aerpio Pharmaceuticals Inc offers 24/7 online support to consumers, and has a team of trained personnel for providing customer services on physical locations (Gillespie & Swan, 2021).

Research and development

The Aerpio Pharmaceuticals Inc makes a substantial investment in research and development. The research and development allows the Aerpio Pharmaceuticals Inc to stay updated with the market and consumer trends – thereby allowing the Aerpio Pharmaceuticals Inc to tailor its offerings and marketing efforts accordingly. The research and development also allows the Aerpio Pharmaceuticals Inc to improve its production processes, and improve efficiency levels continuously (Grewal & Levy, 2021).

Product offering

The Aerpio Pharmaceuticals Inc focuses on maintaining consistent quality for its product offerings. Moreover, the Aerpio Pharmaceuticals Inc also ensures that the product offerings meet the consumer needs and demands. For this purpose, it engages in the localization of its product offerings across different regions and locations (Abratt & Bendixen, 2018).

Financial resources

The financial resources and capability at the Aerpio Pharmaceuticals Inc allows minimum dependence on debt. The Aerpio Pharmaceuticals Inc has a higher dependence on equity for expansion and development purposes. This ensures lower vulnerability of the company, and gives the Aerpio Pharmaceuticals Inc increased freedom and independence for pursuing business objectives and goals (Groucutt & Hopkins, 2015).

Marketing activities

The Aerpio Pharmaceuticals Inc engages in marketing activities for appealing to its target audience across different countries and regions. The marketing communication is tailored to take into account different cultural considerations across these locations and regions. Moreover, the Aerpio Pharmaceuticals Inc ensures to appeal to the functional as well as emotional fronts of the consumers - using insights from its research and development activities (Kotler & Keller, 2021).

Rare

Rare resources for the Aerpio Pharmaceuticals Inc are those which are not easily and readily available for the competing players. These resources are rare for the Aerpio Pharmaceuticals Inc because of the firm’s unique position and access to the resources – which is otherwise difficult and challenging to acquire. This makes rare resources cost-intensive for other organizations (Phillips & Moutinho, 2018).

Manufacturing and distribution licenses

Aerpio Pharmaceuticals Inc has gained special licensing permissions for manufacturing and distribution in various regions ad countries – some of which are more remote and stringent towards international firms. The Aerpio Pharmaceuticals Inc has been able to do so based on its strong team of lawyers and policy interpreters, as well as because of the goodwill it has developed over the years (Kotler & Keller, 2021).

Access to raw materials

Aerpio Pharmaceuticals Inc has access to different raw materials that support its quality maintenance of product offerings. The access to raw materials for the Aerpio Pharmaceuticals Inc is largely based on the company’s unique position and its investments in research and development. Both of these have allowed the Aerpio Pharmaceuticals Inc to substantially develop its capabilities (Buchanan & Huczynski, 2019).

Equipment

The Aerpio Pharmaceuticals Inc has access to world-class equipment. This equipment and technology is not readily and easily available to its competing players. The Aerpio Pharmaceuticals Inc has access to this equipment for increasing efficiency, and improving economies of scale based on its vast operations, and partnerships with various regional governments (McShane & Glinow, 2017).

Intellectual property

The Aerpio Pharmaceuticals Inc has multiple policies regarding intellectual property, and thoroughly implements policies and regulations regarding the same internally. In addition, the company also follows external regulations for intellectual property protection. This allows the Aerpio Pharmaceuticals Inc to sustain its creativity and successfully continue to experiment with new product ideas (Chernev, 2018).

Patents

The Aerpio Pharmaceuticals Inc has different patents registered under its name. This is done by the Aerpio Pharmaceuticals Inc to safeguard its innovative capacities, and maintain regulated intellectual property rights. This helps the Aerpio Pharmaceuticals Inc stay ahead of the competition, and secure new technology and ideas to maintain the first mover, and unique competitive advantage over other players (Wunder, 2019).

Sustainable manufacturing

Based on its unique environment for development and innovation, as well as because of its engagement with advanced technology and equipment, the Aerpio Pharmaceuticals Inc has developed processes for successful sustainable manufacturing. This resource allows the company to appeal to green consumers, and at the same time, maintain higher internal efficiencies and profitability (Tonelli & Cristoni, 2018).

Eco-packaging

The Aerpio Pharmaceuticals Inc is also successfully engaging with, and producing eco-based packaging. This resource is important for the Aerpio Pharmaceuticals Inc, and allows it to improve its processes as well as brand perception. Competing players do not have access to the needed intellectual property, ideas, or machines to successfully, and efficiently apply this to their internal business processes and offerings (Tonelli & Cristoni, 2018).

Inimitable

Inimitable resources for the Aerpio Pharmaceuticals Inc are those which are hard and costly to copy and imitate by other players, and competitive rivals in the industry. Inimitable resources offer a long-term competitive advantage to Aerpio Pharmaceuticals Inc. Aerpio Pharmaceuticals Inc has different resources that are hard to imitate, or are perfectly inimitable largely because of factors of historical context; and unique historical conditions; causal ambiguity, and/or social complexity (Stead & Stead, 2014).

For Aerpio Pharmaceuticals Inc, a number of resources are inimitable because of their uniqueness to the company itself. These include:

Organizational culture

The organizational culture is unique to the Aerpio Pharmaceuticals Inc – developed through the Aerpio Pharmaceuticals Inc’s core values and beliefs, as well as its structure and managing style. The culture of the Aerpio Pharmaceuticals Inc leads to improved employee performance, and facilitates organizational success (Abbas, 2017).

HRM policies and activities

The Aerpio Pharmaceuticals Inc has also built a strong HRM department internally which supports the business, and its strategies. This support is extended through various HRM functions such as hiring, and training activities and opportunities. These activities are aligned with the business goals and strategic direction for ensuring high organizational performance, and the right talent match for the Aerpio Pharmaceuticals Inc (Mariappanadar, 2019).

Compensation Framework

The Aerpio Pharmaceuticals Inc also has a unique compensation system to support internal activities and functions. The compensation system is rooted in employee motivation and needs. The Aerpio Pharmaceuticals Inc invests in understanding the needs of the employees, and then designs rewards accordingly- linking them with the job responsibilities and tasks (Mariappanadar, 2019; DuBrin, 2013).

Brand equity

The Aerpio Pharmaceuticals Inc has developed strong brand equity over time. The Aerpio Pharmaceuticals Inc has successfully, and continually delivered on its brand promise by providing high quality offerings. This has allowed the buildup of consumer trust as well as positive brand perception leading to higher brand equity for Aerpio Pharmaceuticals Inc (Kotler & Keller, 2021).

Brand loyalty

The Aerpio Pharmaceuticals Inc has a high brand loyalty. Based on its offerings, quick customer service, and after-sales service, the Aerpio Pharmaceuticals Inc has developed a high brand loyalty amongst customers. These customers conduct repeat purchases of the Aerpio Pharmaceuticals Inc’s offerings and products because of higher satisfaction levels (Baines, Fill, & Rosengren, 2017).

Brand awareness

The marketing activities of the Aerpio Pharmaceuticals Inc are carefully tailored and targeted, and based on the emotional appeal that the company provides in its offerings to the customers. This in turn leads to a positive buzz. The viral buzz, as well as positive marketing efforts, have led to high brand awareness for the Aerpio Pharmaceuticals Inc amongst not only its own target customers, but also amongst secondary groups (Sahaf, 2019).

Goodwill

Aerpio Pharmaceuticals Inc has continually delivered on its promise, and has thus developed a positive brand perception. As a result of this, the Aerpio Pharmaceuticals Inc has built positive goodwill over the years. This goodwill allows the Aerpio Pharmaceuticals Inc to confidently launch new products in the market that consumers readily accept and consume (Grewal & Levy, 2021).

Innovation

The Aerpio Pharmaceuticals Inc continually engages in innovation and creativity as well. The company has a team for business development that engages in the process of new product design and development. The Aerpio Pharmaceuticals Inc also invests in the creative development of its employees for facilitating and encouraging new idea generation, and emphasizes on employee empowerment for the same purpose (McShane & Glinow, 2017).

Organizational leadership

The Aerpio Pharmaceuticals Inc has a supportive leadership. The leadership style at Aerpio Pharmaceuticals Inc is participative which encourages discussion, and creates trust and a positive work environment. In addition, the leadership at Aerpio Pharmaceuticals Inc is transparent and accessible, and works closely to improve and build the organizational culture through promoting core beliefs and values (Schein, 2010).

Employee commitment

The employees at the Aerpio Pharmaceuticals Inc display high levels of job satisfaction. This is because the Aerpio Pharmaceuticals Inc continually engages the employees with challenging tasks, trainings for personal and professional development, as well as motivational work responsibilities and teamwork. This results in increased levels of job satisfaction amongst employees of Aerpio Pharmaceuticals Inc, leading in turn to high levels of employee commitment (Mariappanadar, 2019).

Branding activities

The Aerpio Pharmaceuticals Inc invests in branding activities for building its brand as well as a positive consumer perception. These branding activities for the Aerpio Pharmaceuticals Inc involve not only the marketing communications, but also the development of a suitable marketing mix for the company. The branding activities help the Aerpio Pharmaceuticals Inc increase brand awareness, as well as increase its reach and penetration amongst the target audience (Iacobucci, 2021).

Organized

The Aerpio Pharmaceuticals Inc is able to capitalize on different opportunities based on the various resources available to it through being organized. This factor of the strategic framework evaluates and assesses how organized and structured the Aerpio Pharmaceuticals Inc is. The factor also reviews how the Aerpio Pharmaceuticals Inc is able to benefit from the various resources that are available to it towards building sustainable competitive advantage (Chatzoglou, Chatzoudes, Sarigiannidis, & Theriou, 2018; Stead & Stead, 2014). This part of the strategic framework for the Aerpio Pharmaceuticals Inc allows it to identify and examine different resources it has closely to be able to optimally benefit from them.

Physical infrastructure

One of the best ways through which the Aerpio Pharmaceuticals Inc is able to capitalize on the various internal and external opportunities is through the development of its physical infrastructure. The infrastructure of the Aerpio Pharmaceuticals Inc allows it to develop economies of scale as well as enhance its various manufacturing and operational processes (Buchanan & Huczynski, 2019).

Technological infrastructure

The technological infrastructure of the Aerpio Pharmaceuticals Inc allows it to benefit from the latest technological trends such as the inclusion of artificial intelligence and automation in its operational processes and schedules. The technological infrastructure has facilitated the Aerpio Pharmaceuticals Inc to improve its production and efficiency rates as well as reduce its errors. The technological infrastructure also led the Aerpio Pharmaceuticals Inc to benefit from potential advancements such as social media marketing and e-commerce (DuBrin, 2013).

Network support

The Aerpio Pharmaceuticals Inc is able to further benefit from consuming of various resources available through the presence of a strong internal network. This network includes not only the physical and technological infrastructure but also the organizational network and alignment of operations locally and globally. This coordination and network allows the Aerpio Pharmaceuticals Inc to realize its strategic goals (Phillips & Moutinho, 2018).

Training and development

As the Aerpio Pharmaceuticals Inc is exposed to new resources and builds on old resources, it is important to update the skills of the employees. The Aerpio Pharmaceuticals Inc continually invests in the training and development of its labor force. This ensures that the Aerpio Pharmaceuticals Inc stays ahead of the competition.

The Aerpio Pharmaceuticals Inc maintains frequent internal training and development opportunities to help the growth of employees and improve their performance (Mariappanadar, 2019; Stead & Stead, 2014).

International Exposure

The growth and expansion of the Aerpio Pharmaceuticals Inc and its business along international fronts have given it considerable exposure to understand different cultural requirements and operational details. This exposure is important for the Aerpio Pharmaceuticals Inc to allocate resources accordingly towards different regions and production sites; and manage them in the most efficient and effective manner possible (Kotler & Keller, 2021).

International learning

The international exposure that the Aerpio Pharmaceuticals Inc also enables increased sharing of knowledge across borders. This knowledge sharing and knowledge development allows continuous learning internally for the Aerpio Pharmaceuticals Inc. This learning then helps the Aerpio Pharmaceuticals Inc to work towards to the development of strategic structures within the organization as well as design more sophisticated management styles and tools to improve the management of resources (Daneshmandnia, 2019).

Organizational hierarchy

Optimization of the resources available to the Aerpio Pharmaceuticals Inc is because the organization has a flatter hierarchy which leads to easier access to the leadership and quicker decision-making processes. This enables higher employee empowerment and participation as well as leads to increased organizational commitment and responsibility (Deepak & Jeyakumar, 2019).

Supportive leadership

The leadership of the Aerpio Pharmaceuticals Inc is largely supportive and ensures the development of the management team and the employees. The support of the leadership within the Aerpio Pharmaceuticals Inc allows space for quicker decisions as well as makes room for capitalizing on the opportunities and mitigating risks accordingly. This in turn allows for improved Resource management and optimization (Schein, 2010).

Effective change management processes

The Aerpio Pharmaceuticals Inc engages all employees in the change management process and ensures that there is transparent communication regarding the need as well as the implementation of the same. This allows the Aerpio Pharmaceuticals Inc to manage resources more effectively as well as build on other resources to help the company achieve its strategic and business objectives and goals (Pollack & Pollack, 2015).

Conclusion

The VRIO assessment is an important strategic tool that allows the Aerpio Pharmaceuticals Inc to identify various resources which can lead to different forms of competitive advantages. The VRIO assessment and model allows the Aerpio Pharmaceuticals Inc to identify resources that can be used for developing sustainable competitive advantage over the long term as well as allows the Aerpio Pharmaceuticals Inc to invest in, and build other resources for the same purpose.

In addition, the strategic tool allows managers of the company to identify resources which can lead to competitive disadvantage. As such the VRIO assessment is an important source of resource evaluation as well as identification of the same.

References:

Abbas, M. (2017). The effect of organizational culture and leadership style towards employee engagement and their impact towards employee loyalty. Asian Journal of Technology and Management Research (AJTMR) ISSN, 2249, 0892.

Abratt, R., & Bendixen, M. (2018). Strategic marketing: Concepts and cases. . New York, United States: Routledge.

Baines, P., Fill, C., & Rosengren, S. (2017). Marketing. New York, United States: Oxford University Press.

Buchanan, D., & Huczynski, A. (2019). Organizational behaviour. London: Pearson UK.

Chatzoglou, P., Chatzoudes, D., Sarigiannidis, L., & Theriou, G. (2018). The role of firm-specific factors in the strategy-performance relationship: Revisiting the resource-based view of the firm and the VRIO framework. Management Research Review.

Chernev, A. (2018). Strategic marketing management. Berlin/Heidelberg, Germany: Cerebellum Press.

Daneshmandnia, A. (2019). The influence of organizational culture on information governance effectiveness. Records Management Journal.

Deepak, R., & Jeyakumar, S. (2019). Marketing management. New Delhi, India: Educreation Publishing.

DuBrin, A. (2013). Fundamentals of organizational behavior: An applied perspective. Amsterdam, Netherlands: Elsevier.

Gillespie, K., & Swan, K. (2021). Global marketing. New York, United States: Routledge.

Grewal, D., & Levy, M. (2021). M: marketing. New York, United States: McGraw-Hill Education.

Groucutt, J., & Hopkins, C. (2015). Marketing. London: Macmillan International Higher Education.

Iacobucci, D. (2021). Marketing management. Boston, Massachusetts, United States: Cengage Learning.

Knott, P. (2015). Does VRIO help managers evaluate a firm’s resources?. Management Decision.

Kotler, P., & Keller, K. (2021). Marketing Management (15th global edition). London, United Kingdom: Pearson Education Limited.

Lasserre, P. (2017). Global strategic management. London: Macmillan International Higher Education.

Mariappanadar, S. (2019). Sustainable human resource management: Strategies, practices and challenges. Macmillan International Higher Education.

McShane, S., & Glinow, M. (2017). Organizational behavior. New York, United States: McGraw-Hill Education.

Phillips, P., & Moutinho, L. (2018). Contemporary issues in strategic management. London: Routledge.

Pollack, J., & Pollack, R. (2015). Using Kotter’s eight stage process to manage an organisational change program: Presentation and practice. Systemic practice and action research, 28(1), 51-66.

Sahaf, A. (2019). Strategic marketing: Making decisions for strategic advantage. New Delhi, India: PHI Learning Pvt. Ltd..

Schein, E. (2010). Organizational culture and leadership . John Wiley & Sons.

Stead, J., & Stead, W. (2014). Sustainable strategic management. . London: Routledge.

Tonelli, M., & Cristoni, N. (2018). Strategic management and the circular economy. London: Routledge.

Wunder, T. (2019). Rethinking strategic management: Sustainable strategizing for positive impact. Berlin: Springer Nature.